多囊卵巢综合征骨骼肌代谢障碍的研究进展

郭晓晓; 庞益伟; 田洪成; 王雁林; 韩磊

doi:10.11659/jjssx.10E022135

您当前的位置：

首页 >

文章列表页 >

多囊卵巢综合征骨骼肌代谢障碍的研究进展

综述 | 更新时间：2023-07-17

- 多囊卵巢综合征骨骼肌代谢障碍的研究进展
- Research progress on metabolic disorder of skeletal muscle in patients with polycystic ovary syndrome
- 局解手术学杂志 2023年32卷第7期页码：645-648
- 作者机构：
  
  1.滨州医学院附属医院生殖医学科，山东滨州 256603
  2.遵义医科大学附属妇幼保健院生殖医学科，贵州遵义 563000
- 作者简介：
  
  韩磊，E-mail：hanleimm@126.com
- 基金信息：
  
  滨州医学院科研计划项目(BY2021KYQD34);滨州医学院附属医院高层次人才科研启动基金(2021-03);遵义市科技计划项目(遵市科合HZ字［2020］271号);遵义市红花岗区科技计划项目(遵红科合社字（2020）07号)
- DOI：10.11659/jjssx.10E022135
  中图分类号： R711.75
- 纸质出版日期：2023-07-25，
  
  收稿日期：2022-10-26，
扫描看全文
郭晓晓,庞益伟,田洪成等.多囊卵巢综合征骨骼肌代谢障碍的研究进展[J].局解手术学杂志,2023,32(07):645-648.

GUO Xiao-xiao,PANG Yi-wei,TIAN Hong-cheng,et al.Research progress on metabolic disorder of skeletal muscle in patients with polycystic ovary syndrome[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2023,32(07):645-648.
郭晓晓,庞益伟,田洪成等.多囊卵巢综合征骨骼肌代谢障碍的研究进展[J].局解手术学杂志,2023,32(07):645-648. DOI： 10.11659/jjssx.10E022135.

GUO Xiao-xiao,PANG Yi-wei,TIAN Hong-cheng,et al.Research progress on metabolic disorder of skeletal muscle in patients with polycystic ovary syndrome[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2023,32(07):645-648. DOI： 10.11659/jjssx.10E022135.

摘要

多囊卵巢综合征（PCOS）是影响女性健康最常见的生殖内分泌疾病之一，也是辅助生殖助孕的一项重要指征。大量研究证实PCOS患者发生胰岛素抵抗（IR）、2型糖尿病、非酒精性脂肪肝和心血管疾病的风险显著升高，因此PCOS已成为影响患者终身健康的代谢性疾病。尽管IR并非PCOS的诊断标准，但PCOS患者中IR普遍存在且病理生理特征明显。雄激素在IR发生过程中具有双向调节效应，两者之间存在复杂的相互作用。骨骼肌是雄激素作用的靶器官，在维持代谢稳态中发挥关键作用，也是胰岛素介导葡萄糖利用的主要场所。近年来，骨骼肌代谢功能障碍在PCOS发病中的作用逐渐成为学界关注的焦点。分析PCOS女性骨骼肌代谢功能障碍的特征及可能的分子机制，或将为改善PCOS患者的代谢功能提供新的治疗思路。

Abstract

Polycystic ovary syndrome （PCOS） is one of the most common reproductive endocrine diseases affecting women's health. It is also an important indication of assisted reproduction and pregnancy. A large number of studies have confirmed that PCOS patients have a significantly increased risk of insulin resistance （IR），type 2 diabetes mellitus，non-alcoholic fatty liver disease and cardiovascular disease，therefore PCOS has been a metabolic disease that affects the lifelong health of patients. Although IR is not a diagnostic criterion for PCOS，IR is common and has obvious pathophysiological characteristics in PCOS patients. Androgens have bidirectional regulatory effects in the process of IR development，and there is a complex interaction between them. Skeletal muscle is the target organ of androgen action，which plays a key role in maintaining metabolic homeostasis，and is also the main site where insulin mediates glucose utilization. In recent years， the role of skeletal muscle metabolic dysfunction in the pathogenesis of PCOS has gradually become the focus of academic attention. Analyzing the characteristics and possible molecular mechanisms of skeletal muscle metabolic dysfunction in women with PCOS，may provide new therapeutic ideas for improving the metabolic function of PCOS patients.

关键词

高雄激素胰岛素抵抗多囊卵巢综合征骨骼肌代谢障碍

Keywords

androgen excessinsulin resistancepolycystic ovary syndromeskeletal musclemetabolic disorder

references

Shi YQ， Wang Y， Zhu XT， et al. The application of complementary and alternative medicine in polycysticovary syndrome infertility［J］.Evid Based Complement Alternat Med， 2022，2022：507606.doi：10.1155/2022/5076306http://dx.doi.org/10.1155/2022/5076306.

Chen T， Yu Y， Jia F， et al. The relationship between polycystic ovary syndrome and insulin resistance from1983 to 2022： a bibliometric analysis［J］. Front Public Health， 2022，10：960965.doi：10.3389/fpubh.2022.960965http://dx.doi.org/10.3389/fpubh.2022.960965.

管桂雪，濮义福. 多囊卵巢综合征患者骨骼肌氧化应激基因的识别及其转录因子的预测［J］. 中国优生与遗传杂志， 2022，30（9）：1560-1566.doi：10.13404/j.cnki.cjbhh.2022.09.032http://dx.doi.org/10.13404/j.cnki.cjbhh.2022.09.032.

DeFronzo RA， Hendler R， Simonson D. Insulin resistance is a prominent feature of insulin-dependent diabetes［J］. Diabetes， 1982，31（9）：795-801.doi：10.2337/diab.31.9.795http://dx.doi.org/10.2337/diab.31.9.795.

Hargreaves M， Spriet LL. Skeletal muscle energy metabolism during exercise［J］. Nat Metab， 2020，2（9）：817-828.doi：10.1038/s42255-020-0251-4http://dx.doi.org/10.1038/s42255-020-0251-4.

McDonnell T， Cussen L， McIlroy M， et al. Characterizing skeletal muscle dysfunction in women withpolycysticovarysyndrome［J］. Ther Adv Endocrinol Metab， 2022，13：1859484876.doi：10.1177/204201 88221113140http://dx.doi.org/10.1177/20420188221113140.

Morales PE， Bucarey JL， Espinosa A. Muscle lipid metabolism： role of lipid droplets and perilipins［J］. J Diabetes Res， 2017：1789395.doi：10.1155/2017/1789395http://dx.doi.org/10.1155/2017/1789395.

Yazıcı D， Sezer H. Insulin resistance， obesity and lipotoxicity［J］. Adv Exp Med Biol， 2017，960：277-304.doi：10.1007/978-3-319-48382-5_12http://dx.doi.org/10.1007/978-3-319-48382-5_12.

Brioche T， Pagano AF， Py G， et al. Muscle wasting and aging： Experimental models， fatty infiltrations，and prevention［J］. Mol Aspects Med， 2016，50：56-87.doi：10.1016/j.mam.2016.04.006http://dx.doi.org/10.1016/j.mam.2016.04.006.

Samuel VT， Petersen KF， Shulman GI. Lipid-induced insulin resistance： unravelling the mechanism［J］. Lancet， 2010，375（9733）：2267-2277.doi：10.1016/S0140-6736（10）60408-4http://dx.doi.org/10.1016/S0140-6736（10）60408-4.

Montgomery MK， Turner N. Mitochondrial dysfunction and insulin resistance： an update［J］. Endocr Connect， 2015，4（1）：R1-R15.doi：10.1530/EC-14-0092http://dx.doi.org/10.1530/EC-14-0092.

Stepto NK， Moreno-Asso A， McIlvenna LC， et al. Molecular mechanisms of insulin resistance in polycystic ovary syndrome： unraveling the conundrum in skeletal muscle？［J］. J Clin Endocrinol Metab， 2019，104（11）：5372-5381.doi：10.1007/s40279-019-01133-6http://dx.doi.org/10.1007/s40279-019-01133-6.

Persson S， Elenis E， Turkmen S， et al. Higher risk of type 2 diabetes in women with hyperandrogenicpolycysticovarysyndrome［J］.Fertil Steril，2021，116（3）：862-871.doi：10.1016/j. fertnstert.2021. 04.018http://dx.doi.org/10.1016/j.fertnstert.2021.04.018.

Stepto NK， Cassar S， Joham AE， et al.Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp[J].Hum Reprod,2013,28(3):777-784.doi: 10.1093/humrep/des463http://dx.doi.org/10.1093/humrep/des463.

Xu S， Liu Y， Xue K， et al. Diagnostic value of total testosterone and free androgen index measured by LC-MS/MS for PCOS and insulin resistance［J］. J Clin Lab Anal， 2022：e24739.doi：10.1016/j.fertnstert.2021.04.018http://dx.doi.org/10.1016/j.fertnstert.2021.04.018.

Ruth KS， Day FR， Tyrrell J， et al. Using human genetics to understand the disease impacts of testosteronein men and women［J］.Nat Med， 2020，26（2）：252-258.doi：10.1038/s41591-020-0751-5http://dx.doi.org/10.1038/s41591-020-0751-5.

Cassar S， Misso ML， Hopkins WG， et al. Insulin resistance in polycystic ovary syndrome： a systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies［J］. Hum Reprod， 2016，31（11）：2619-2631.doi：10.1093/humrep/dew243http://dx.doi.org/10.1093/humrep/dew243.

Yao Q， Zou X， Liu S， et al. Oxidative stress as a contributor to insulin resistance in the skeletal musclesof mice with polycystic ovary syndrome［J］.Int J Mol Sci， 2022，23（19）：11384.doi：10.3390/ijms231911384http://dx.doi.org/10.3390/ijms231911384.

Dunaif A， Wu X， Lee A， et al. Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome（PCOS）［J］.Am J Physiol Endocrinol Metab， 2001，281（2）：E392-E399.doi：10.1152/ajpendo.2001.281.2.E392http://dx.doi.org/10.1152/ajpendo.2001.281.2.E392.

Bouzakri K， Zachrisson A， Al-Khalili L， et al. siRNA-based gene silencing reveals specialized roles of IRS-1/Akt2 and IRS-2/Akt1 in glucose and lipid metabolism in human skeletal muscle ［J］. Cell Metab， 2006，4（1）：89-96.doi：10.1016/j.cmet.2006.04.008http://dx.doi.org/10.1016/j.cmet.2006.04.008.

Huang C， Thirone AC， Huang X， et al. Differential contribution of insulin receptor substrates 1 versus 2 to insulin signaling and glucose uptake in I6 myotubes［J］. J Biol Chem， 2005，280（19）：19426-19435.doi：10.1074/jbc.M412317200http://dx.doi.org/10.1074/jbc.M412317200.

Højlund K， Glintborg D， Andersen NR， et al. Impaired insulin-stimulated phosphorylation of Akt and AS160 in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment［J］. Diabetes， 2008，57（2）：357-366.doi：10.2337/db07-0706http://dx.doi.org/10.2337/db07-0706.

Hansen SL， Svendsen PF， Jeppesen JF， et al. Molecular mechanisms in skeletal muscle underlying insulin resistance in women who are lean with polycystic ovary syndrome［J］. J Clin Endocrinol Metab， 2019，104（5）：1841-1854.doi：10.1210/jc.2018-01771http://dx.doi.org/10.1210/jc.2018-01771.

Rimmer M， Tan BK， Teede H， et al. Metabolic inflexibility in women with polycystic ovary syndrome：asystematic review［J］. Gynecol Endocrinol， 2020，36（6）：501-507.doi：10.1080/09513590. 2019.1698025http://dx.doi.org/10.1080/09513590.2019.1698025.

Thyfault JP， Rector RS， Noland RC. Metabolic inflexibility in skeletal muscle： a prelude to the cardiometabolic syndrome？［J］. J Cardiometab Syndr， 2006，1（3）：184-189.doi：10.1111/j.1559-4564.2006.05629.xhttp://dx.doi.org/10.1111/j.1559-4564.2006.05629.x.

Kumarendran B， O'Reilly MW， Subramanian A， et al. Polycystic ovary syndrome， combined oral contraceptives， and the risk of dysglycemia： a population-based cohort study with a nested pharmacoepidemiological case-control study［J］. Diabetes Care， 2021，44（12）：2758-2766.doi：10.2337/dc21-0437http://dx.doi.org/10.2337/dc21-0437.

Diamond MP， Grainger D， Diamond MC， et al. Effects of methyltestosterone on insulin secretion and sensitivity in women［J］. J Clin Endocrinol Metab， 1998，83（12）：4420-4425.doi：10.1210/jcem. 83.12.5333http://dx.doi.org/10.1210/jcem.83.12.5333.

Polderman KH， Gooren LJ， Asscheman H， et al. Induction of insulin resistance by androgens and estrogens［J］. J Clin Endocrinol Metab， 1994，79（1）：265-271.doi：10.1210/jcem.79.1.8027240http://dx.doi.org/10.1210/jcem.79.1.8027240.

Zang H， Carlström K， Arner P， et al. Effects of treatment with testosterone alone or in combination with estrogen on insulin sensitivity in postmenopausal women［J］. Fertil Steril， 2006，86（1）：136-144.doi：10.1016/j.fertnstert.2005.12.039http://dx.doi.org/10.1016/j.fertnstert.2005.12.039.

Joham AE， Norman RJ， Stener-Victorin E， et al. Polycystic ovary syndrome［J］. Lancet Diabetes Endocrinol， 2022，10（9）：668-680.doi：10.1016/S2213-8587（22）00163-2http://dx.doi.org/10.1016/S2213-8587（22）00163-2.

O'Reilly MW， Kempegowda P， Jenkinson C， et al. 11-oxygenated C19 steroids are the predominant androgens in polycystic ovary syndrome［J］. J Clin Endocrinol Metab， 2017，102（3）：840-848.doi：10.1210/jc.2016-3285http://dx.doi.org/10.1210/jc.2016-3285.

Tosi F， Villani M， Garofalo S， et al. Clinical value of serum levels of 11-oxygenated metabolites of testosterone in women with polycystic ovary syndrome［J］. J Clin Endocrinol Metab， 2022，107（5）：e2047-e2055.doi：10.1210/clinem/dgab920http://dx.doi.org/10.1210/clinem/dgab920.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

多囊卵巢综合征诊断分型与候选基因研究进展

TGF-β微泡靶向治疗大鼠骨骼肌损伤的实验研究